Cancer researchers tap computers to support preclinical go/no-go decisions

Researchers have developed a computational cancer model to predict how a drug will perform in humans, VentureBeat reports. The in silico system has shown how breast cancer cells develop resistance to drugs, a capability its developers think can influence clinical candidate selection. Article